Mifepristone/Misoprostol

米非司酮/米索前列醇

Report date: 2025/11/17 14:45:28

Base Information

Drug NameMifepristone/Misoprostol
Drug Alias NameMisoprostol/Mifepristone米索前列醇米非司酮米非司酮米索前列醇Mifepristone and Misoprostol米索前列醇/米非司酮 +[10
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor antagonistsProstanoid EP2 receptor antagonists
TargetsProstanoid EP2 receptorProgesterone receptor
Therapy Area/IndicationsTerminate pregnancy
Global Approved IndicationsTerminate pregnancy
Approved Indications in ChinaN/A
Original Approved Country/TerritorySweden
Original Approved Date2012/01/01
Country/TerritorySwedenJapan
CombinationsYes MisoprostolMifepristone
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTerminate pregnancy
Inactive IndicationsN/A

Other Information

ATC CodeG03XB01
Related LinksN/A